Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Status:
NOT_YET_RECRUITING
Trial end date:
2029-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), in combination with cognitive behavioral therapy (CBT) for the treatment of cocaine use disorder (CUD).
Phase:
PHASE2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston